Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe licensed weekly dose of semaglutide for weight management ranges from 0.25 mg at the start of treatment right up to 2.4 mg (or the newer 7.2 mg maintenance option) at the top of the schedule — with your prescriber setting the pace. As a prescription-only medicine, the amount you take each week is determined through clinical assessment, not self-selection. Private UK pricing for Wegovy typically runs from around £149 to £375 per month depending on dose and provider, though what that price actually covers varies considerably. Learn more about how Wegovy works before looking at where the cost lands.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
NICE's appraisal of semaglutide for weight management (TA875) is built around a titration schedule that begins at 0.25 mg weekly and steps up through 0.5 mg, 1.0 mg and 1.7 mg before reaching the 2.4 mg maintenance dose, each step taken roughly four weeks apart, at the prescriber's discretion. That graduated approach is deliberate. The STEP 1 trial, published in the New England Journal of Medicine, showed around 15% average body weight reduction over 68 weeks at the 2.4 mg dose, the weekly amount the whole schedule is designed to reach safely. In January 2026 the MHRA also approved a 7.2 mg maintenance dose, later supplied via a dedicated single-dose pen approved in April 2026, for adults with a BMI of 30 or above. That higher ceiling brings the potential weekly dose for some patients to three times what was previously standard. What stays constant across every dose level is the clinical framework around it: a prescriber sets it, reviews it and adjusts it. No one dose is right by default.
Private Wegovy pricing is sold per pen, and each pen covers four weekly doses, so the monthly cost and the weekly dose are the same conversation. From September 2025, Eli Lilly revised the UK list price for Mounjaro (tirzepatide, the comparable alternative), with the highest-dose pen rising from around £122 to around £330; Wegovy pricing from private providers has tracked a similar range. As reported across the pharmacy sector, private semaglutide treatment typically costs somewhere between £149 and £375 per month depending on the dose and the service. The lower end of that range tends to correspond to the starter doses; the upper end to the higher maintenance doses. Worth knowing: the weekly dose you are on when you order determines the pen strength you need, which determines the price tier. If you are moving up the schedule, our page on the Wegovy 2.7 mg price explains what to expect at that particular step, useful if you are thinking ahead to payday or want to factor in a holiday. A full breakdown of what the monthly cost looks like by dose makes this easier to plan around.
A quoted price for semaglutide online can mean several different things. At its most stripped-back, it covers the medicine alone. More often the advertised number excludes the consultation fee (some providers charge £20–£50 or more), the prescription fee, delivery charges, or any clinical support between doses. Those extras add up quickly, and they are not trivial, a prescriber-reviewed consultation before every repeat supply is a legal requirement, not an optional service tier. At nume, sorry. At our pharmacy, one transparent price includes the consultation, the prescription, the medicine and tracked next-working-day delivery, with aftercare included. We are not the cheapest option available. That is a deliberate choice: speed, genuine clinical oversight and a fully regulated supply chain cost something, and we do not cut those corners to win a price comparison. More on what drives the total cost of semaglutide treatment, and how to read a price honestly.
Semaglutide is a Prescription-Only Medicine. The MHRA has issued clear public guidance that GLP-1 medicines are not assessed for quick or cosmetic weight loss, and has warned repeatedly about fake pens sold without a prescription through social media and unverified online sellers. Large seizures of counterfeit weight-loss pens have been made across the UK, with some containing insulin rather than semaglutide. Choosing a provider because their quoted price is lowest is a reasonable instinct for most purchases. For a POM, it is the wrong test: the right questions are whether the pharmacy is registered on the GPhC register, whether a qualified prescriber reviews your case before every supply, and whether the medicine comes from the licensed UK supply chain. You can report any suspect seller or unexpected side effect at the MHRA's Yellow Card scheme. Start a free consultation with our prescribers if you want to understand which dose and treatment would suit your situation, the clinical picture always comes before the pricing one. For a broader look at results, this page covers how much weight loss per week you can realistically expect on Wegovy, based on the available evidence. This page covers what the evidence says about weekly weight loss on semaglutide.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.